doi: 10.1371/journal.pmed.0050152 16 KapoorN.PawarS.SirakovaT
Patients at risk include those with a history of atherosclerosis, multiple cardiovascular risk factors, advanced age, impaired cardiac output, coagulation disorders, prolonged periods of immobilization, and/or known/suspected hyperviscosity. For postexposure prophylaxis indications, HepaGam B must be administered intramuscularly only
Plant Signaling & Behavior 12, e1356531
10.1515/med-2024-0963 Summary Keywords ferroptosis, recurrent miscarriage (RM), therapeutic interventions, trophoblast dysfunction, glutathione peroxidase 4 Citation Khodaei MM, Noori Z, Zare F and Meshkin A (2025) Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets